Efficacy and safety of FDG-PET for determining target volume during intensity-modulated radiotherapy for head and neck cancer involving the oral level.

Yasuo KosugiKeisuke SasaiNaoya MurakamiTatsuki KarinoYoichi MuramotoTerufumi KawamotoMasaki OshimaNoriyuki OkonogiJun TakatsuKotaro IijimaShuhei KarubeAkira IsobeNaoya HaraMitsuhisa FujimakiShinichi OhbaFumihiko MatsumotoKoji MurakamiNaoto Shikama

Published in: EJNMMI reports (2024)

The results suggest that the target volume determined by PET-CT could safely reduce GTV size and interobserver variability in patients with locally advanced HNSCC extending into the oral cavity or oropharynx undergoing IMRT. Trial registration UMIN, UMIN000033007. Registered 16 jun 2018, https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037631.

Keyphrases

pet ct
locally advanced
rectal cancer
positron emission tomography
neoadjuvant chemotherapy
squamous cell carcinoma
radiation therapy
phase ii study
early stage
clinical trial
study protocol
phase iii
phase ii
radiation induced
open label
lymph node
pet imaging
placebo controlled
double blind